Skip to main content

Want a detailed portfolio tracker?

Zai Lab (ZLAB) P/E (2020 - 2026)

Zai Lab (ZLAB) P/E from Dec 31, 2020 to Jul 21, 2026. The TTM Zai Lab (ZLAB) P/E is -12.71. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Zai Lab (ZLAB)

YearP/EChange
2026-12.71+15.18%
2025-11.04+7.41%
2024-10.28+17.12%
2023-8.77+42.66%
2022-6.15-37.45%
2021-9.83-92.55%
2020-132.01N/A

Comparison Zai Lab (ZLAB) P/E with competitors

Zai Lab (ZLAB) P/E is -12.71.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.03%
ENLVEnlivex Ltd0.07-100.59%
FGENFibroGen Inc0.24-101.89%
CHRSCoherus Biosciences Inc0.85-106.67%
FBIOFortress Biotech Inc0.95-107.46%
ORMPOramed Pharmaceuticals Inc1.50-111.82%
AGENAgenus Inc3.01-123.67%
INVAInnoviva Inc3.15-124.81%
VXRTVaxart Inc3.55-127.92%
CRMDCorMedix Inc3.63-128.54%
CVACCureVac N.V.4.45-134.97%
GLPGGalapagos NV4.86-138.22%
SRPTSarepta Therapeutics Inc4.88-138.40%
ABEOAbeona Therapeutics Inc5.39-142.38%
ABUSArbutus Biopharma Corp5.60-144.01%
ZVRAZevra Therapeutics Inc5.89-146.31%
SPROSpero Therapeutics Inc6.23-148.99%
CGENCompugen Ltd6.31-149.66%
RIGLRigel Pharmaceuticals6.87-154.05%
SLXNSilexion Therapeutics Corp7.30-157.39%
OMEROmeros Corporation9.26-172.82%
AUPHAurinia Pharmaceuticals Inc9.58-175.39%
PLXProtalix BioTherapeutics Inc10.89-185.66%
ACADAcadia Pharmaceuticals Inc11.73-192.25%
TBPHTheravance Biopharma Inc12.26-196.45%
ADMAAdma Biologics Inc12.42-197.68%
HRMYHarmony Biosciences Holdings Inc13.82-208.70%
SABSSAB Biotherapeutics Inc14.14-211.19%
NAGENiagen Bioscience Inc14.82-216.55%
INCYIncyte Corp15.82-224.45%
REGNRegeneron Pharmaceuticals Inc15.86-224.72%
PBYIPuma Biotechnology Inc17.32-236.20%
CPRXCatalyst Pharmaceuticals Inc17.44-237.17%
EXELExelixis Inc17.54-237.95%
TGTXTG Therapeutics Inc18.97-249.18%
MDXGMimedx Group Inc20.55-261.66%
XOMAXOMA Royalty Corp22.87-279.93%
ARGXArgen X SE24.30-291.12%
CTMXCytomX Therapeutics Inc24.82-295.24%
XOMAOXOMA Royalty Corp25.34-299.36%
HALOHalozyme Therapeutics Inc25.62-301.55%
XOMAPXOMA Royalty Corp25.67-301.91%
VRTXVertex Pharmaceuticals Inc27.99-320.20%
RPRXRoyalty Pharma plc - Class A28.69-325.65%
SLNOSoleno Therapeutics Inc29.02-328.23%
ASNDAscendis Pharma A/S30.09-336.65%
LGNDLigand Pharmaceuticals Inc - Class B37.91-398.21%
APLSApellis Pharmaceuticals Inc39.02-406.93%
BMRNBiomarin Pharmaceutical Inc42.21-432.03%
KRYSKrystal Biotech Inc45.34-456.66%
ONCBeiGene Ltd69.54-646.99%
PHARPharming Group N.V.75.03-690.13%
TECHBio-Techne Corp101.96-901.98%
VCELVericel Corp109.92-964.61%
ALNYAlnylam Pharmaceuticals Inc117.96-1027.88%
GMABGenmab140.29-1203.49%
TLXTelix Pharmaceuticals Ltd162.15-1375.45%
CORTCorcept Therapeutics Inc212.86-1774.28%